EUVIMEDEUVIMED entdecken
Open Access · CC BY-SA 4.0

In Silico-Based Screening of Vannamei Shrimp Myosin Protein as a Potential Source of Antihypertensive and Antidiabetic Bioactive Peptides

Erwina Safitri, Septi Nur Rachmawati, Holif Fitriyah, Baiq Dewi Sukma Septiani, Ellanda Rima Ervyanna, Mutiara Vidianinggar

Jurnal Teknologi dan Industri Pangan · 21.11.2026 · 37 (3) · 258-270

DOI: 10.6066/jtip.2026.37.3.258 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Jurnal Teknologi dan Industri Pangan, online erschienen am 21.11.2026. Verfasst von Erwina Safitri und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vannamei shrimp (Penaeus vannamei) is an important aquaculture commodity and a potential source of bioactive peptides with diverse health benefits. However, its myosin protein remains underexplored as a source of the peptides. This study aimed to predict antihypertensive and antidiabetic activities of the peptides derived from the shrimp’s myosin using an in silico approach. The myosin sequence was retrieved from the National Center for Biotechnology Information (NCBI) database (GenBank accession number: ROT81-948.1). Basic Local Alignment Search Tool (BLAST) analysis revealed high similarity to myosin heavy chains from several shrimp species, with 93-100% query coverage and 87.67 and 91.43% identity values. Enzymatic hydrolysis was simulated using Bioactive Peptides Database (BIOPEP-UWM) to predict bioactive peptide release. The ficin-bromelain combination released 30 unique bioactive dipeptides, compared with 23 sequences from ficin-papain combination, and produced more dipeptides associated with ACE- and DPP-IV-inhibitory activities. Five dipeptides (EK, DR, EG, IR, and NY) were predicted to exhibit dual ACE- and DPP-IV-inhibitory effects. EA and DL emerged as the most frequent ACE-inhibitory peptides, whereas AL and QL were the most frequent DPP-IV-inhibitory peptides. All identified dipeptides had average molecular weights of

Zitieren

APA

Safitri, E., Rachmawati, S. N., Fitriyah, H., Septiani, B. D. S., Ervyanna, E. R., & Vidianinggar, M. (2026). In Silico-Based Screening of Vannamei Shrimp Myosin Protein as a Potential Source of Antihypertensive and Antidiabetic Bioactive Peptides. Jurnal Teknologi dan Industri Pangan, 37(3), 258-270. https://doi.org/10.6066/jtip.2026.37.3.258

Vancouver

Safitri E, Rachmawati SN, Fitriyah H, Septiani BDS, Ervyanna ER, Vidianinggar M. In Silico-Based Screening of Vannamei Shrimp Myosin Protein as a Potential Source of Antihypertensive and Antidiabetic Bioactive Peptides. Jurnal Teknologi dan Industri Pangan. 2026;37(3):258-270. doi:10.6066/jtip.2026.37.3.258

BibTeX
@article{Safitri2026,
  author = {Safitri, Erwina and Rachmawati, Septi Nur and Fitriyah, Holif and Septiani, Baiq Dewi Sukma and Ervyanna, Ellanda Rima and Vidianinggar, Mutiara},
  title = {In Silico-Based Screening of Vannamei Shrimp Myosin Protein as a Potential Source of Antihypertensive and Antidiabetic Bioactive Peptides},
  journal = {Jurnal Teknologi dan Industri Pangan},
  year = {2026},
  volume = {37},
  number = {3},
  pages = {258--270},
  doi = {10.6066/jtip.2026.37.3.258}
}
Kostenlos starten →